...
首页> 外文期刊>Psychoneuroendocrinology: An International Journal >Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
【24h】

Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.

机译:通过地塞米松/ CRH和生长激素释放激素测试评估精神病性抑郁症的纵向神经内分泌变化。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Although psychotic depression has been reported to exhibit a greater degree of dysregulation of hypothalamic-pituitary-adrenocortical (HPA) function than non-psychotic depression, little is known concerning hypothalamic-pituitary-somatotropic (HPS) function in psychotic depression and how neuroendocrine function changes after treatment. To investigate the longitudinal changes in HPA and HPS system function in psychotic depression, we performed repeated dexamethasone/corticotropin releasing hormone (DEX/CRH) tests and growth hormone (GH) releasing hormone (GHRH) tests in inpatients with major depressive disorder. The psychotic depression group exhibited greater elevation of ACTH responses to the DEX/CRH test and stronger decreases in GH responses to the GHRH test than the non-psychotic depression group at admission. At discharge, the neuroendocrine responses to the DEX/CRH test of the psychotic depression group were still stronger than those of the non-psychotic depression group, though there were no significant differences in severity of depression between the groups. There were significant longitudinal changes in neuroendocrine responses to the DEX/CRH test between admission and discharge. The psychotic depression group exhibited increased GH responses to GHRH at discharge compared with those at admission, whereas no significant longitudinal change in GH response was found in the non-psychotic depression group. Consequently, there were no significant differences in GH responses to GHRH between the psychotic and non-psychotic depression groups at discharge. The results of GHRH test showed no significant relationships with severity of depression except psychotic features and the results of the DEX/CRH test. Our findings suggest that the HPS axis may be associated with psychotic features rather than general severity of depression. Further longitudinal studies are needed to clarify the role of HPS function in psychotic depression and whether sustained dysregulation of HPA function in psychotic depression isassociated with a poor outcome after discharge.
机译:尽管据报道精神病性抑郁症比非精神病性抑郁症表现出更大程度的下丘脑-垂体-肾上腺皮质激素(HPA)功能失调,但对于精神病性抑郁症的下丘脑-垂体-促生长激素(HPS)功能以及神经内分泌功能如何变化知之甚少治疗后。为了研究精神抑郁症患者HPA和HPS系统功能的纵向变化,我们对重度抑郁症患者进行了反复的地塞米松/促肾上腺皮质激素释放激素(DEX / CRH)测试和生长激素(GH)释放激素(GHRH)测试。与入院时的非精神病性抑郁症组相比,精神病性抑郁症组对DEX / CRH测试的ACTH反应升高幅度更大,对GHRH试验的GH反应下降幅度更大。出院时,精神病性抑郁症组对DEX / CRH测试的神经内分泌反应仍然强于非精神病性抑郁症组,尽管两组之间抑郁症的严重程度没有显着差异。在入院和出院之间,神经内分泌对DEX / CRH测试的反应有明显的纵向变化。与入院时相比,精神病抑郁组在出院时对GHRH的GH反应增强,而非精神病抑郁组未发现GH反应的纵向显着变化。因此,精神病和非精神病性抑郁症患者出院时对GHRH的GH反应无显着差异。 GHRH测试结果显示,除精神病特征和DEX / CRH测试结果外,与抑郁的严重程度无明显关系。我们的发现表明,HPS轴可能与精神病特征有关,而不是与抑郁的一般严重程度有关。需要进一步的纵向研究来阐明HPS功能在精神病性抑郁症中的作用以及精神病性抑郁症中HPA功能的持续失调是否与出院后不良结局有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号